Overview

A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Adalimumab